Kymera Therapeutics announced new clinical trials for KT-621, targeting atopic dermatitis and asthma, with data expected in 2025 and 2026. Kymera Therapeutics has announced the initiation of ...

April 22, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical ... severe atopic dermatitis (AD). The Company expects to report data from the BroADen trial in the fourth ...

(MENAFN- GlobeNewsWire - Nasdaq) Data from the BroADen Phase 1b atopic dermatitis (AD ... initiated dosing in its BroADen Phase 1b clinical trial evaluating KT-621, an oral, highly selective ...

today announced that it recently initiated dosing in its BroADen Phase 1b clinical trial evaluating KT-621, an oral, highly selective, potent degrader of STAT6, in patients with moderate to severe ...

In adults with atopic dermatitis, moisturizers with anti-inflammatory ingredients significantly improved skin hydration and ...

This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.

Kymera Therapeutics (KYMR) announced that it recently initiated dosing in its BroADen Phase 1b clinical ... atopic dermatitis. The Company expects to report data from the BroADen trial in the ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

Here, the authors report a phase 2 clinical trial investigating immune activation and efficacy of neoadjuvant pembrolizumab administered after one cycle of neo-adjuvant chemotherapy in patients ...

While both guidelines present varying levels of evidence for the use of numerous treatments for AD, Disease Management of Atopic Dermatitis ... includes a section on clinical diagnosis that ...